HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Tadao Uraoka Selected Research

Spasm (Spasms)

7/2015Overview of the Acetylcholine Spasm Provocation Test.
5/2010Coronary abnormal response has increased in Japanese patients: analysis of 17 years' spasm provocation tests in 2093 cases.
4/2008Recommendations for performing acetylcholine tests safely: STOP dangerous complications induced by acetylcholine tests (STOP DCIAT).
11/2005Need for documentation of guidelines for coronary artery spasm: an investigation by questionnaire in Japan.
12/2004Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.
7/2004Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine.
12/2003Did the widespread use of long-acting calcium antagonists decrease the occurrence of variant angina?
9/2003Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.
9/2003Coronary flow reserve in patients with vasospastic angina: correlation between coronary flow reserve and age or duration of angina.
9/2002Intracoronary administration of a thromboxane A2 synthase inhibitor relieves acetylcholine-induced coronary spasm.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Tadao Uraoka Research Topics

Disease

11Spasm (Spasms)
07/2015 - 06/2002
2Chest Pain (Chest Pains)
02/2007 - 09/2002
2Muscle Spasticity (Spastic)
02/2007 - 02/2003
1Coronary Artery Disease (Coronary Atherosclerosis)
05/2010
1Cardiac Tamponade
04/2008
1Ventricular Tachycardia
04/2008
1Shock
04/2008
1Hypovolemia
04/2008
1Atrial Fibrillation
04/2008
1Pathologic Constriction (Stenosis)
02/2003

Drug/Important Bio-Agent (IBA)

8Acetylcholine (Acetylcholine Chloride)FDA Link
07/2015 - 06/2002
6Ergonovine (Ergometrine)IBA
07/2015 - 09/2003
5Phenobarbital (Luminal)FDA Link
05/2010 - 06/2002
2Isosorbide Dinitrate (Isordil)FDA LinkGeneric
02/2007 - 12/2004
2CalciumIBA
02/2007 - 02/2003
1cifenline (cibenzoline)IBA
04/2008
1Norepinephrine (Noradrenaline)FDA LinkGeneric
04/2008
1iodofiltic acidIBA
02/2007
1Nicorandil (SG 75)IBA
02/2007
1Adenosine Triphosphate (ATP)IBA
09/2003
1ozagrelIBA
09/2002
1Thromboxane A2 (A2, Thromboxane)IBA
09/2002